Striving for positive outcomes for patients on mechanical ventilation continues to be a challenge for healthcare providers.  Patients experiencing respiratory failure from acute or chronic illness, trauma, and post-surgical care continue to grow in numbers and complexity.  Chronic respiratory diseases, unintentional injury, (which includes trauma), influenza/pneumonia, and septicemia are still in the top 10 leading causes of death for all age groups in the United States.1 Mechanical ventilation is used as an adjunct to keep patients alive while other interventional procedures can be used to reverse the injury or disease process.  

 

This conference is designed to enhance the multi-disciplinary team approach and continuing professional development to effectively manage all respiratory failure patients needing mechanical ventilation.   Target audience is nurses, respiratory therapists, pharmacists, physicians, physician assistants, nurse practitioners, pre-hospital, chaplains, and all other healthcare personnel working with this patient population.  It is the goal of the multi-disciplinary team to provide the best care in order to facilitate the best possible recovery and patient outcomes.  

 

1Centers for Disease Control and Prevention, WISQARS™, www.cdc.gov/injury/wisqars.

 

For more conference information, contact Lisa Boyer, RN, BSN, lisa.boyer@coxhealth.com or the education department at 417-269-4117, education@coxhealth.com.

FRIDAY, SEPTEMBER 29, 2017

By attending this educational activity participants should be able to integrate some or all of the objectives as listed.  
7:30 – 7:50 Registration/Breakfast/Vendor Exhibits
7:50 – 8:00 Welcome/Overview of the Day

                          James Coulter, MD, FACP,Physician Moderator

8:00 – 9:00 ARDS pathophysiology: why does it make the Lung so susceptible to VILI

       Gary Nieman, Associate Professor

  • Identify the pathologic tetrad of ARDS and to explain the mechanisms by which they contribute to VILI
9:00 – 10:00   The New Frontier in Pulmonary and Critical Care: Precision Medicine

       Terry Coulter, MD FACCP, FSSCM, FAASM

  •   Identify the application of genetic mapping toward pulmonary disease
  •   Identify the application of genetic mapping toward critical illnesses
  •   State the use of Precision Medicine and choice of therapy to improve outcomes and enhance cost effective care
10:00 – 10:30 Break/Vendor Exhibits
10:30 – 11:30 Sepsis Recognition with Biomarkers to guide Treatment

       Tom Ahrens, PhD, RN, FAAN  

  • Identify the reasons sepsis is one of the most important public health issues
  • Identify the role of the nurse in the identification & assessment of the patient in severe sepsis
  • Discuss how use of lactate, ScvO2 & potentially StO2 can aid in evaluation of the severity of sepsis
  • Discuss the key components of sepsis treatment
11:30 – 12:30   Lunch (provided on site)
12:30 – 1:30 Matching the Mechanical Breath with Dynamic alveolar Pathophysiology to reduce VILI

         Gary Nieman, Associate Professor

  • Explain the mechanism of dynamic alveolar inflation and using this knowledge to describe the optimal mechanical breath necessary to protect the lung
1:30 – 2:30 Hemodynamic Monitoring – Best Technologies

          Tom Ahrens, PhD, RN, FAAN  

  • Identify the most evidenced based method for measuring stroke volume
2:30-2:50 Break/Vendor Exhibits
2:50 – 3:50 Organ Donation and Management of the Organ Donor

          Gary F Marklin MD

  • Identify the steps in managing an organ donor at an independent organ recovery center
  • Identify and describe the factors involved in the organ allocation algorithm
3:50-4:50 Beyond bronchodilators: Inhaled medications and their application

           Amy Ford-Turner, DO

  • TBD
4:50-5:00 Evaluations/Statements of Credit/Adjourn
We reserve the right to substitute speakers and topics in case of emergency or cancellation. Information presented during this conference represents the views and opinions of the presenters and does not necessarily constitute the opinion, endorsement of, or promotion by CoxHealth.  Presenters are responsible for obtaining all copyright permissions.  
No sponsorship or commercial support has been received for this activity. No Off Label medications or medical devices will be discussed.

 

SATURDAY, SEPTEMBER 30, 2017

By attending this educational activity participants should be able to integrate some or all of the objectives as listed.  
7:30 – 7:50 Registration/Breakfast Buffet/Vendor Exhibits
7:50 – 8:00 Welcome/Overview of the Day

                    James Coulter, MD, FACP,Physician Moderator

8:00 – 9:00 ”Invasive Ventilation: State of the Art!”            

        Robert M. Kacmarek, PhD, RRT, FCCM, FCCP, FARC

  • Discuss what is meant by lung protective ventilation and how to apply it
  • Discuss the rationale for using lung protective ventilation on all patients requiring ventilatory support      
9:00 – 10:00   Nutritional Therapy in the Critically Ill Patient:  A Focus on Guidelines and Goal Directed Therapy      

Karrie L Derenski, PharmD, BCSNP, CNSC   

  • Outline guideline recommendations for timely safe and effective use of parenteral and enteral nutrition in adult ICU patients     
  • Apply available guidelines and evidence to ICU case presentation
10:00 – 10:20 Break/Vendor Exhibits
10:20 – 11:20 “Patient-Ventilator Synchrony and Impact on Outcome”

              Robert M. Kacmarek, PhD, RRT, FCCM, FCCP, FARC

  • Discuss the various types of asynchrony commonly observed during assisted ventilation and approaches to minimize the frequency
  • Discuss the impact that high levels of asynchrony have on patient outcome
11:20-11:30 Final Questions & Summation
11:30 Evaluations/Statements of Credit/Adjourn

CoxHealth Education Center is an approved provider of continuing nursing education by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

10.0 Contact Hours

Day 1 is 7.0 Contact Hours and Day 2 is 3.0 Contact Hours

This program has been approved for 10.0 contact hours continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care, 9425 N. MacArthur Blvd. Suite 100, Irving TX 75063.  Credit is for 7.0 contact hours for Day 1 and 3.0 contact hours for Day 2.

This program has been deemed appropriate for chaplains to list 10.0 contact hours of continuing education credit.  Credit should be listed on the Association of Professional Chaplains Annual Summary of Continuing Education Hours Form in the area of Workshops/Conferences/Seminars/Symposia.”    Day 1 is 7.0 contact hours and Day 2 is 3.0 contact hours.

CoxHealth Prehospital Services is an approved provider of continuing education by the Missouri Department of Health and Senior Services, Bureau of EMS. This activity has been approved for 10.0 contact hours.  The Training Center number is 07710C.  Day 1 is 7.0 contact hour and Day 2 is 3.0 contact hours.

Pharmacy credit is pending

For questions regarding educational credit please contact Lisa Boyer, RN, BSN at 417-269-4124, lisa.boyer@coxcollege.edu.  

Accreditation approval only refers to this educational activity and does not imply endorsement of any commercial products by CoxHealth or any proprietary entity producing health care goods or services.

STATEMENT OF CREDIT AND REPLACEMENT FEE

Participants will receive statements of credit at the end of the program when all requirements for credit have been met.  Satisfactory completion of objectives will occur through program attendance.  Therefore the participant is required to attend the entire day.  In order to receive a statement of credit, all participants must sign-in at the registration desk and complete an on-line evaluation form at the end of each day.  Credit will be provided per day.

Participants who need a statement of credit replaced at a later date will be charged a $5.00 replacement fee.  To request a duplicate statement of credit please contact the main education office at 417-269-4117 or email educationcenternorth@coxcollege.edu.

Americans with Disabilities Act: If you have special needs addressed by this act, please notify us at least two weeks before this offering so that reasonable efforts will be made to accommodate your needs.  

Note: Please bring a sweater or jacket due to variations in temperature and personal preferences.  

Cancellations received in writing to EducationCenterNorht@coxhealth.com by September 20, 2017 will be entitled to a full refund. After this time, a $25 processing fee will be withheld.  No refunds will be made the day of the conference.  No shows will be charged the full conference fee.

In the event the Education Center cancels or reschedules a course, participants are entitled to a full refund or the participant may transfer registration to the next scheduled activity.

CoxHealth is not responsible for travel, hotel, booking fees, or other cancellation fees for registrants when an activity is cancelled.

All refunds must be received in writing via email or by calling the Education Center.

Chateau on the Lake – In order to get the special room rate of $159 (based on single or double occupancy) be sure to tell them you need the CoxHealth rate http://www.chateauonthelake.com/.  Be sure to book early in order to get the special rate.

Tom Ahrens, PhD, RN, FAAN
Research Scientist
Barnes-Jewish Hospital
St. Louis, MO

 

Terry Coulter, MD FACCP, FSSCM, FAASM
Chairman, Dept of Pulmonary, Critical Care, and Sleep Medicine
Director, Respiratory Care; Physician Planner
Ferrell-Duncan Clinic
Springfield, MO

 

Karrie L Derenski, PharmD, BCSNP, CNSC
Clinical Supervisor, Clinical Pharmacy Services
CoxHealth
Springfield, MO

 

Robert M. Kacmarek, PhD, RRT, FCCM, FCCP, FARC
Professor of Anesthesia
Harvard Medical School
Director of Respiratory Care
Massachusetts General Hospital
Boston, Mass.

 

Gary F Marklin, MD  
Pulmonary and Critical Care Physician
Chief Medical Officer & Consulting Physician in Pulmonary and Critical Care Medicine
Mid-America Transplant Services & Saint Anthony’s Pulmonary Specialists
St Louis, MO

 

Gary Nieman, BA   
Associate Professor
Senior Research Scientist
Director, Cardiopulmonary and Critical Care Laboratory
Upstate Medical University
Syracuse, New York

 

Amy Turner, DO
Physician
Ferrell-Duncan Clinic
Springfield, MOAmy Turner, DO

Lisa Boyer, RN, BSN
Enterprise Educator
Educational Center

 

Terry Coulter, MD FACCP, FSSCM, FAASM
Chairman, Dept of Pulmonary, Critical Care, and Sleep Medicine
Director, Respiratory Care; Physician Planner
Ferrell-Duncan Clinic

 

James Coulter, MD, FACP
Medical Director and Pulmonologist
Select Specialty Hospital
Springfield, MO

 

James Dameron, BA, RRT, CPFT, RCP
Operations Supervisor
Respiratory Care

 

Kris Jones, R, Ph
Critical Care Pharmacist
Pharmacy, CoxHealth
Springfiled, MO

 

Paul Luehrs, RRT, BSRT, BSEd
Adult Critical Care Supervisor
Respiratory Care

 

Martin Rohrer, BS, RRT, RCP, CPFT
Assistant Director
Respiratory Care

 

Debbie West, BS, EMT-P
EMS Educator/PI/EMS Credit Consultant
Pre-Hospital Services

 

Planning committee member, Lisa Boyer has indicated she is a stockholder in the following companies:  Johnson & Johnson, Express Scripts,, Humana Incorporated, and Novartis AG ADR.  She has indicated that she DOES NOT intend to discuss any uses of pharmaceutical products or medical devices not approved by the FDA.  Ms. Boyer also indicated she would give a balanced view of therapeutic options, and will use generic name to contribute to impartiality during the planning process.  There was no conflict identified that would exclude her from the planning process.

 

Speaker, Robert Kacmarek has indicated that he is a consultant for Covidien, has done lectures for Maquet, and has participated in Research Grants for Hollister and Covidien.  He has indicated that he DOES NOT intend to discuss any uses of pharmaceutical products or medical devices not approved by the FDA.  Mr. Kacmarek also indicated he would give a balanced view of therapeutic options, and will use generic name to contribute to impartiality during the planning process.  There was no conflict identified that would exclude him from the planning process
All other Speakers and the following planning committee members: James Dameron, Martin Rohrer, Paul Luehrs, Terry Coulter, Kris Jones, and Debbie West, for this activity have indicated they do not have any conflicts of interest or significant financial affiliations, nor do any of their spouses or partners, with any pharmaceutical or medical device companies. Planning committee members and speakers have created this activity without bias or influence from all commercial entities. No conflicts were noted that would exclude the speakers or the planning committee members from this activity.